Physician profile
Jared Magee
NPI 1699133900
$8,660.43
in general payments reported to CMS, 2019-2025
7 companies · $51.56 in 2025
The $51.56 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.58 · 2023: $7,394 · 2024: $1,191 · 2025: $51.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Travel and Lodging: $2,332 · Food and Beverage: $780 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Travel and Lodging | $2,331.65 |
| Food and Beverage | $779.50 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $7,394.08 | 2023-2024 | Omvoh |
| Boston Scientific Corporation | $1,188.47 | 2024-2025 | Apollo Esg Nxt System, General - Hemostasis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.60 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | |
| Nestle Healthcare Nutrition INC. | $23.58 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.